INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Want A Smooth RTSM Build? Start With These Three Tips

  Effective RTSM planning requires listening to PM guidance, escalating unclear protocol points efficiently, and designing systems that allow for real clinical judgment. 

• How Life Sciences Leaders Are Preparing For More Curveballs In 2026

  Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.

• Beyond Go-Live: The True RTSM Quality Test

  Go‑live is only the beginning. This clip highlights how RTSM performance evolves over years of real‑world use — and why long‑term flexibility is just as important as a clean launch.

• Reducing Human Error With A Blinding Engine

  In this 1-minute clip, see how this RTSM's blinding engine automates the blinding setup process, removing risk before it starts.

• Addressing Opportunities And Challenges In Digital Health Data

  10/22/2024

  Experts from diverse industry sectors unpack key points from the FDA’s final guidance on Digital Health Technologies (DHT) for remote data collection in clinical investigations.

• Building A Clinical Research AI Governance Framework

  6/15/2026

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• Navigating The Enrollment Bottleneck In Early Oncology Trials

  1/12/2026

  Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

• The Problem With Adding RTSM Software Into An eClinical Suite

  5/13/2026

  RTSM software is very different from other eClinical tools, and trying to bundle it into an all-in-one platform can sometimes create more challenges than advantages.

• Optimizing The Rater Journey

  7/10/2025

  For scalable CNS trials, central rating models, where a select group of expert raters conduct remote assessments, offer a way to standardize data collection globally while enhancing patient accessibility and inclusion.